[-] Show simple item record

dc.contributor.authorLoomis, Lucy W.eng
dc.contributor.authorLee, Jay H.eng
dc.contributor.authorTweed, Elizabeth M.eng
dc.date.issued2006-03eng
dc.description.abstractNo evidence clearly supports the practice of increased fetal surveillance in the pregnancies of women with well-controlled (ie, fasting blood sugar <105 mg/dL) class A1 gestational diabetes (strength of recommendation [SOR]: B, consistent retrospective cohort studies). However, a number of guidelines recommend beginning surveillance of some kind between 32 and 40 weeks based on cumulative risk factors, including gestational diabetes (SOR: C, expert opinion).eng
dc.identifier.citationJournal of Family Practice, 55(3) 2006: 238-240.eng
dc.identifier.urihttp://hdl.handle.net/10355/3517eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2006 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectglucose toleranceeng
dc.subjectA1 gestational diabeteseng
dc.subjectneonatal complicationseng
dc.subject.lcshGlucose tolerance testseng
dc.subject.lcshDiabetes in pregnancyeng
dc.titleWhat is appropriate fetal surveillance for women with diet-controlled gestational diabetes?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record